EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

The association between prescription drug monitoring programs and controlled substance prescribing: a cross-sectional study using data from 2019 National Electronic Health Records Survey

Shivani Mehta iD, William Brown, Erin Ferguson, James Najera, Matthew S Pantell

Journal of the American Medical Informatics Association · 2023

DOI: 10.1093/jamia/ocad053 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of the American Medical Informatics Association, 2023. Verfasst von Shivani Mehta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Prescription Drug Monitoring Programs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIMHD NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The use of controlled medications such as opioids, stimulants, anabolic steroids, depressants, and hallucinogens has led to an increase in addiction, overdose, and death. Given the high attributes of abuse and dependency, prescription drug monitoring programs (PDMPs) were introduced in the United States as a state-level intervention. Materials and methods Using cross-sectional data from the 2019 National Electronic Health Records Survey, we assessed the association between PDMP usage and reduced or eliminated controlled substance prescribing as well as the association between PDMP usage and changing a controlled substance prescription to a nonopioid pharmacologic therapy or nonpharmacologic therapy. We applied survey weights to produce physician-level estimates from the survey sample.

Results

Adjusting for physician age, sex, type of medical degree, specialty, and ease of PDMP, we found that physicians who reported “often” PDMP usage had 2.34 times the odds of reducing or eliminating controlled substance prescriptions compared to physicians who reported never using the PDMP (95% confidence interval [CI] 1.12–4.90). Adjusting for physician age, sex, type of doctor, and specialty, we found that physicians who reported “often” use of the PDMP had 3.65 times the odd of changing controlled substance prescriptions to a nonopioid pharmacologic therapy or nonpharmacologic therapy (95% CI: 1.61–8.26).

Discussion

These results support the continued use, investment, and expansion of PDMPs as an effective intervention for reducing controlled substance prescription and changing to nonopioid/pharmacologic therapy.

Conclusion

Overall, frequent usage of PDMPs was significantly associated with reducing, eliminating, or changing controlled substance prescription patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prescription Drug Monitoring ProgramsUnited StatesCross-Sectional StudiesControlled SubstancesElectronic Health RecordsPractice Patterns, Physicians'

Stichwörter der Autor:innen

National Electronic Health Records Surveycontrolled substance prescribingprescription drug monitoring programssurvey methods

Substanzen

Controlled Substances

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Department of Medicine, Center for Vulnerable Populations, University of California, San Francisco, San Francisco, California, USA.
  • Bakar Computational Health Science Institute, University of California, San Francisco, San Francisco, California, USA.
  • Center for Digital Health Innovation, University of California San Francisco School of Medicine, San Francisco, California, USA.
  • Department of Medicine, Division of Prevention Science, Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, California, USA.
  • Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Shivani Mehta

Förderung

  • NCATS NIH HHS
  • NIMHD NIH HHS
  • AHRQ HHS
  • NIH HHS
  • NICHD NIH HHS
  • NIA NIH HHS
  • NIDA NIH HHS
  • National Institute on Minority Health and Health Disparities

Zitieren

APA

Mehta, S., Brown, W., Ferguson, E., Najera, J., & Pantell, M. S. (2023). The association between prescription drug monitoring programs and controlled substance prescribing: a cross-sectional study using data from 2019 National Electronic Health Records Survey. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocad053

Vancouver

Mehta S, Brown W, Ferguson E, Najera J, Pantell MS. The association between prescription drug monitoring programs and controlled substance prescribing: a cross-sectional study using data from 2019 National Electronic Health Records Survey. Journal of the American Medical Informatics Association. 2023. doi:10.1093/jamia/ocad053

BibTeX
@article{Mehta2023,
  author = {Mehta, Shivani and Brown, William and Ferguson, Erin and Najera, James and Pantell, Matthew S},
  title = {The association between prescription drug monitoring programs and controlled substance prescribing: a cross-sectional study using data from 2019 National Electronic Health Records Survey},
  journal = {Journal of the American Medical Informatics Association},
  year = {2023},
  doi = {10.1093/jamia/ocad053}
}
Kostenlos starten →